Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1. - Archive ouverte HAL Access content directly
Journal Articles Journal of Virological Methods Year : 2013

Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1.

(1) , (1) , (2) , (1) , (3) , (2)
1
2
3

Abstract

Lentiviral vectors (LVs) are promising delivery systems for gene therapy. To enhance the efficiency of target cell transduction by LVs, protocols often include the addition of culture additives. In this study, the cationic amphipathic peptide LAH4-L1 (KKALLAHALHLLALLALHLAHALKKA), a DNA transfection agent, was evaluated for its capacity to improve LV infectivity in cell lines and primary cells. Results show that LAH4-L1 enhances infectivity of all LV pseudotypes tested, particularly GALVTR-LVs. More importantly, LAH4-L1 promotes the transduction of CD34+ hematopoietic stem cells with GALVTR-LVs as efficiently as Retronectin, a culture additive used in ex vivo clinical protocols involving LVs. The action of LAH4-L1 relies both on the GALVTR-LV adhesion and post-adhesion steps. LAH4-L1 represents a new and attractive transduction enhancer for hematopoietic gene therapy protocols.
Fichier principal
Vignette du fichier
VIRMET_12075_proof.pdf (478.18 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00800499 , version 1 (14-03-2013)

Identifiers

Cite

David Fenard, Sandrine Genries, Daniel Scherman, Anne Galy, Samia Martin, et al.. Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1.. Journal of Virological Methods, 2013, 189 (2), pp.375-8. ⟨10.1016/j.jviromet.2013.02.005⟩. ⟨inserm-00800499⟩
856 View
536 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More